Psychosocial factors in adults with chronic kidney disease: Characteristics of pilot participants in the Tasmanian Chronic Kidney Disease study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  McKercher, Charlotte M ^a   Venn, Alison J ^a   Blizzard, Leigh ^a   Nelson, Mark R ^a   Palmer, Andrew J ^a   Ashby, Michael A ^a,b   Scott, Jennifer L ^a,c   Jose, Matthew D ^a,b,c  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Anxiety; Chronic kidney disease; Cohort; Depression; Health related quality of life; Social support

Indexed keywords

CREATININE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; AUSTRALIA; BECK ANXIETY INVENTORY; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DECISION MAKING; DIALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PILOT STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; SOCIAL PSYCHOLOGY; SOCIAL STATUS; SOCIAL SUPPORT;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SOCIAL SUPPORT; TASMANIA;

EID: 84876907174     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-83     Document Type: Article

References (53)

1. Collaborative care for patients with depression and chronic illnesses. Katon W, Lin E, Korff M, Ciechanowski P, Ludman E, Young B, Peterson D, Rutter C, McGregor M, McCulloch D, New Engl J Med 2010 363 2611 2620
2. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Sareen J, Jacobi F, Cox B, Belik S, Clara I, Stein M, Arch Intern Med 2006 166 2109 2116
3. Social relationships and health. House J, Landis K, Umberson D, Science 1988 241 540 545
4. Psychosocial and behavioral interventions for chronic medical conditions. Fekete E, Antoni M, Schneiderman N, Curr Opin Psychiatry 2007 20 152 157
5. Australian Institute of Health and Welfare (AIHW), Chronic Kidney Disease in Australia Canberra: AIHW 2005
6. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Lopes A, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port F, Kidney Int 2002 62 199 207
7. Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Hedayati SS, Bosworth HB, Briley LP, Sloane RJ, Pieper CF, Kimmel PL, Szczech LA, Kidney Int 2008 74 930 936
8. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, Veis JH, Kidney Int 2000 57 2093 2098
9. Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. Hedayati S, Minhajuddin A, Afshar M, Toto R, Trivedi M, Rush A, JAMA 2010 303 1946 1953
10. Association of symptoms of depression with progression of CKD. Tsai Y-C, Chiu Y-W, Hung C-C, Hwang S-J, Tsai J-C, Wang S-L, Lin M-Y, Chen H-C, Am J Kidney Dis 2012 60 54 61
11. Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes. Kop WJ, Seliger SL, Fink JC, Katz R, Odden MC, Fried LF, Rifkin DE, Sarnak MJ, Gottdiener JS, CJASN 2011 6 834 844
12. Anxiety disorders in adults treated by hemodialysis: a single-center study. Cukor D, Coplan J, Brown C, Friedman S, Newville H, Safier M, Spielman LA, Peterson RA, Kimmel PL, Am J Kidney Dis 2008 52 128 136
13. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, Veis JH, Kidney Int 1998 54 245 254
14. The associations of social support and other psychosocial factors with mortality and quality of life in the Dialysis Outcomes and Practice Patterns Study. Untas A, Thumma J, Rascle N, Rayner H, Mapes D, Lopes AA, Fukuhara S, Akizawa T, Morgenstern H, Robinson BM, Pisoni RL, Combe C, CJASN 2011 6 142 152
15. Social support predicts survival in dialysis patients. Thong MS, Kaptein AA, Krediet RT, Boeschoten EW, Dekker FW, Nephrol Dial Transplant 2007 22 845 850
16. Chronic kidney disease in Tasmania. Jose MD, Otahal P, Kirkland G, Blizzard L, Nephrology 2009 14 743 749
17. Clinical Audit Tool (CAT), [ http://www.clinicalaudit.com.au/ ]
18. The PHQ-9: validity of a brief depression severity measure. Kroenke K, Spitzer R, Williams J, J Gen Intern Med 2001 16 606 613
19. An inventory for measuring clinical anxiety: psychometric properties. Beck A, Epstein N, Brown G, Steer R, J Consult Clin Psychol 1988 56 893 897
20. The Multidimensional Scale of Perceived Social Support. Zimet GD, Dahlem NW, Zimet SG, Farley GK, J Pers Assess 1988 52 30 41
21. Validation of 2 depression screening tools in dialysis patients. Watnick S, Wang P, Demadura T, Ganzini L, Am J Kidney Dis 2005 46 919 924
22. Beck A, Steer R, Beck Anxiety Inventory manual San Antonio, TX: Psychological Corporation 2 1993
23. Psychometric evaluation of the Beck Anxiety Inventory with older medical patients. Wetherell J, Areán P, Psychol Assess 1997 9 136 144
24. Spirituality, social support, and survival in hemodialysis patients. Spinale J, Cohen S, Khetpal P, Peterson R, Clougherty B, Puchalski C, Patel S, Kimmel P, CJASN 2008 3 1620 1627
25. Australian Bureau of Statistics (ABS), Census of population and housing: socio-economic indexes for areas (SEIFA) Canberra: ABS 2001
26. An improved comorbidity index for outcome analyses among dialysis patients. Liu J, Huang Z, Gilbertson DT, Foley RN, Collins AJ, Kidney Int 2009 77 141 151
27. National Heart Lung and Blood Institute, Clinical Guidelines for the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: The Evidence Report Bethesda, MD: National Heart, Lung, and Blood Institute 1998
28. The Modified Mini-Mental State (MMS) examination. Teng E, Chui H, J Clin Psychiatry 1987 48 314 318
29. Development of the Kidney Disease Quality of Life (KDQOL) Instrument. Hays R, Kallich J, Mapes D, Coons S, Carter W, Qual Life Res 1994 3 329 338
30. The clinical evaluation of chemotherapeutic agents in cancer. Karnofsky D, Burchenal J, Evaluation of Chemotherapeutic Agents in Cancer New York: Columbia University Press, McLeod C, 1949 191 205
31. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. Katz S, Ford A, Moskowitz R, Jackson B, Jaffe M, JAMA 1963 185 914 919
32. Assessment of older people: self-maintaining and instrumental activities of daily living. Lawton M, Brody E, Gerontologist 1969 9 179 186
33. Measuring patients' desire for autonomy: decision making and information-seeking preferences among medical patients. Ende J, Kazis L, Ash A, Moskowitz M, J Gen Intern Med 1989 4 23 30
34. Assessment of preferences for self-treatment and information in health care. Krantz D, Baum A, Wideman M, J Pers Soc Psychol 1980 39 977 990
35. Validation of the Kidney Disease Quality of Life (KDQOL) Cognitive Function subscale. Kurella M, Luan J, Yaffe K, Chertow GM, Kidney Int 2004 66 2361 2367
36. Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease. McClellan WM, Anson C, Birkeli K, Tuttle E, J Clin Epidemiol 1991 44 83 89
37. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Levey A, Am J Kidney Dis 2002 39 266
38. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Levey A, Coresh J, Greene T, Stevens L, Zhang Y, Hendriksen S, Kusek J, Van Lente F, Ann Intern Med 2006 145 247 254
39. The construct and concurrent validity of the EQ-5D in a renal transplant population. Cleemput I, Kesteloot K, Moons P, Vanrenterghem Y, Van Hooff JP, Squifflet J-P, De Geest S, Value in Health 2004 7 499 509
40. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Liem Y, Bosch J, Myriam Hunink M, Value in Health 2008 11 733 741
41. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. Wyld M, Morton RL, Hayen A, Howard K, Webster AC, PLoS Med 2012 9 1001307
42. Australian Bureau of Statistics, National Survey of Mental Health and Wellbeing: summary of results 2007 Canberra: ABS 2008
43. Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease. Porter A, Fischer M, Brooks D, Bruce M, Charleston J, Cleveland W, Dowie D, Faulkner M, Gassman J, Greene T, Hiremath L, Kendrick C, Kusek J, Thornley-Brown D, Wang X, Norris K, Unruh M, Lash J, Translational Research 2012 159 4 11
44. Understanding the neurobiology of comorbidity in anxiety disorders. Nutt D, Stein D, CNS Spectrums 2006 11 13 20
45. Dimensions of social support in the MSPSS: factorial structure, reliability, and theoretical implications. Kazarian SS, McCabe SB, J Community Psychol 1991 19 150 160
46. Australian Bureau of Statistics, National Health Survey: SF36 population norms, Australia Canberra: ABS 1995
47. Pain, sleep disturbance, and quality of life in patients with chronic kidney disease. Cohen S, Patel S, Khetpal P, Peterson R, Kimmel P, CJASN 2007 2 919 925
48. Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. Leyfer O, Ruberg J, Woodruff-Borden J, J Anxiety Disord 2006 20 444 458
49. European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam Pilot studies. Schröder FH, Denis LJ, Kirkels W, De Koning HJ, Standaert B, Cancer 1995 76 129 134
50. Participation rates in epidemiologic studies. Galea S, Tracy M, Ann Epidemiol 2007 17 643 653
51. Cass A, Chadban S, Craig J, Howard H, McDonald S, Salkeld G, White S, The economic impact of end-stage kidney disease in Australia: Projections to 2020 Melbourne: Kidney Health Australia 2010
52. Australian Institute of Health and Welfare (AIHW), End-stage kidney disease in Australia: total incidence, 2003-2007 Canberra: AIHW 2011
53. Risk factors for dialysis withdrawal: an analysis of the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, 1999-2008. Chan HW, Clayton PA, McDonald SP, Agar JW, Jose MD, CJASN 2012 7 775 781